The MRC OX-44 antigen marks a functionally relevant subset among rat thymocytes by unknown
THE MRC OX-44 ANTIGEN MARKS A FUNCTIONALLY
RELEVANT SUBSET AMONG RAT THYMOCYTES
BY DAVIDJ. PATERSON, JON R. GREEN, WILFRED A. JEFFERIES,
MICHAEL PUKLAVEC, AND ALAN F. WILLIAMS
From theMedical Research Council Cellular Immunology Unit, Sir William Dunn School of
Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom
The immunocompetent T lymphocytes that are found in the peripheral
lymphoid tissue can be subdivided into three sets on the basis of cell surface
marker antigens. The first set to be identified includes the precursors for
cytotoxic Tcells that are specific for, or restricted by, class I MHC antigens and
these are marked by expression of the CD8 antigen (1-3). Complementing this
set are the restofthe peripheral T cells that express the CD4 antigen and include
T helper cells and precursors for cytotoxic cells whose specificity involves the
class II MHC antigens (3-6). The CD4' cells can be further subdivided into one
set that includes cells providing help for B cells and another that contains the
cells that initiate the MLR and provide help for CTL (7).
In the thymus 10-15% of the cells have phenotypes apparently similar to
peripheral T cells in that they express either CD4 or CD8 antigens (but not both)
and contain cells that can function as precursors to cytotoxic T cells (CD4-
CD8+) or T helper cells (CD4+ CD8-) (8-11). These cells are found largely in
the medulla, whereas the great majority ofthe remaining cells express both CD4
and CD8antigens and are found largely in the cortex (12, 13). Functional activity
from the CD4+ CD8+ cells has not been identified in studies in the mouse (9),
and these cells have the additional unusual feature of expressing very low levels
ofclass I MHC antigens (14, 15). The CD4- CD8- set constitutes only 1-2% of
thymocytes but these cells can reconstitute all other populations either in vivo
when injected intravenously into irradiated recipients (16), or in vitro when
added to fetal thymic lobes in culture (17).
The lineage relationships between the various populations ofcells in the thymus
are largely unknown and new markers are needed if these are to be resolved.
We now describe an antibody called MRC OX-44 that labels all leukocytes in
the periphery but only 10-15% in the thymus. Functional studies lead to the
working hypothesis that the OX-44+ cells include all thymocytes that are on the
pathway to immunocompetent T lymphocytes.
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Materials and Methods
Animals. Strains used were HO (RT1`, leukocyte-common antigen [L-CA]' 1.2),
HO.B2 (RT1"), DA (RTIa), and (HO X HO.B2) F,. All were from the Specific Pathogen-
free Unit at the Medical Research Council Cellular Immunology Unit, Oxford. HO
'Abbreviations used in this paper:
￿
L-CA, leukocyte-common antigen; RAM, rabbit anti-mouse
F(ab')2; TDL, thoracic duct lymphocyte.
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(RT1`, L-CA 1 .1) rats were maintained under conventional conditions. Chimeric rats were
prepared by irradiating HO.B2 rats (9-12 wk) with 950 rad of 7-irradiation (from a' s'Cs
source at 87 rad/min) followed by reconstitution with 5-10 X 10' bone marrow cells i .v.
per rat from the F, hybrid 5-6 h later.
Antibodies.
￿
A hybridoma secreting the MRC OX-44 mAb (IgG,) was derived from a
fusion between BALB/C mouse spleen cells and the mouse myeloma NSO/1 following
methods as in Galfre and Milstein (18). The mouse had been immunized with T lympho-
blasts from an MLR between purified rat T helper cells and irradiated semiallogeneic rat
spleen, as described in Jefferies et al. (19). Rabbit anti-mouse F(ab')2 (RAM) and its
fluorescein isothiocyanate (RAM-FITC) and horseradish peroxidase (RAM-peroxidase)
conjugates were prepared as previously described (20, 21). Other mAbs used were MRC
OX-1, anti-L-CA common determinant (22); MRC OX-8, anti-CD8 (2); MRC OX-18,
anti-class I MHC common determinant (15); MRC OX-19, anti-rat CD-5 (Lyt-1) (23);
MRC: OX-27, anti-class I MHC RT1` haplotype (19); MRC OX-35 and MRC OX-38,
noncompeting anti-CD4 mAbs (19); MRC OX-42, anti-rat C3b receptor (24). ED2, anti-
rat tissue macrophages (25), was the kind gift of Dr. C. D. Dijkstra, Free University,
Amsterdam, The Netherlands; NDS 58, anti-RT-7 .1 (anti-L-CA1 .2) (26), was the kind
gift of Dr. M. R. Newton, Department of Zoology, University of Oxford; 8G6.1, anti-
RT-7 .2 (anti-L-CA 1 .1) alloantigen (27) was the kind gift of Dr. D. L. Greiner, University
ofConnecticut Health Center, Farmington CT; Bu20a, reactive with bromodeoxyuridine2
was the kind gift of Dr. J.-P. Magaud, Department of Haematology, John Radcliffe
Hospital, Oxford. MRC OX-21, anti-human C3b 1NA, was used as a control mAb.
Cells.
￿
Thoracic duct lymphocytes (TDL) were collected overnight into ice-cold Dul-
becco's A + B medium (DAB) containing 20 U/ml heparin. Thymus, spleen, and cervical
lymph nodes were removed aseptically, and either teased apart with forceps or pushed
through a square metal mesh of 0.09-mm2 pore size, filtered through lens tissue, and
washed twice in DAB/0.2% BSA.
Bone marrow cells were removed from femur and tibia into ice-cold DAB/0.2% BSA
by syringing. Cells were filtered, washed twice, and injected in a volume of 1 ml of
DAB/0.2% BSA for the preparation of radiation bone marrow chimeras.
For intrathymic injections, thymocytes were prepared in Hepes/RPMI 1640 with 2.5%
FCS.
Immunoprecipitation. HO TDL were ' 251 surface-labeled using the lactoperoxi-
dase/glucose oxidase method (28) and a 1 % NP-40 detergent extract was prepared.
Material that could bind to OX-44 antibody was precipitated and visualized on 12% SDS-
PAGE gels by autoradiography using methods exactly as described by Jefferies et al. (29).
In Vitro Proliferation Assays.
￿
For the primary semiallogeneic MLR, varying numbers
of responder HO thymocytes were cultured with 5 X 105 irradiated (HO X HO.B2)F,
spleen cells (1,800 rad) for 4 d in RPMI 1640 containing 2.5 X 10-5 M 2-mercaptoethanol,
antibiotics, and 5% DA serum .
For the Con A stimulation assay, HO thymocytes were incubated for 3 d with 10
jug/ml-' Con A, 5 X 105 HO-irradiated spleen cells (1,800 rad), and 25 A.1 of a Con A
supernatant (produced by incubating 5 X 106 HO spleen cells/ml for 24 h with 5 wg/ml-'
Con A in the above medium with FCS in place of DA serum).
Culture volumes were 0.2 ml in sterile 96-well U-bottomed microtiter plates at 37°C
in a humidified incubator with 5% C02. 0.5 uCi of [sH]thymidine (Amersham Interna-
tional, Amersham, United Kingdom) was added 18 h before cells were collected onto
glass-fiber filters for determination of radioactivity incorporated.
Staining ofThymus In Situ.
￿
Thymi were removed from HO (4-8 wks) or chimeric rats,
dissected, immediately embedded in OCT (R. A. Lamb, London), and frozen in 2-
methylbutane cooled by liquid nitrogen. Cryostat sections (5 /m) were cut, dried in a
stream of warm air, and fixed in ethanol for 10 min at 4'C. Sections were stained by the
immunoperoxidase technique (21), and counterstained with Harris's hematoxylin.
For staining sections with the Bu20a mAb the method of Magaud et al. 2 was used.
2 Magaud, J.-P., I. Sargeant, J. Clark, and D. Y. Mason. 1986. Immunocytochemical labeling with
monoclonal antibromodeoxyuridine. Manuscript in preparation.PATERSON ET AL.
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Briefly, sections were fixed in acetone for 10 min at 4°C, air dried, incubated in 95%
formamide for 35 min at 67°C, washed in PBS, and then stainedas usual.
Rosette Depletion.
￿
This was carried out as described by Mason (30). Briefly, thymocytes
were labeled with mAb(s), washed, and mixed with SRBC coated with RAM IgG for 20
minat VC. C. Rosettes formed between labeled thymocytes andSRBC-RAM were removed,
and the remaining cells were treated with ammonium chloride in Tris buffer to lyse
erythrocytes and then washed. The success of depletion was assessed by labeling pre- and
postdepletion samples with RAM-FITC, and analyzing on the FACS.
Thymus Repopulation Assay.
￿
The assay of Goldschneider et al. (27) was used. HO L-
CA1.2 rats (5-7 wk old) were given 600 rad and injected intrathymically with HO L-
CA 1.1 thymocytes 6-8 h later. Donor cells, present in 20 ul of PBS, were injected into
four to six sites per thymus at ^"3-5 A,1 per site. Donor reconstitution was assessed by
analyzing host thymi on the FACS 14 d later.
Results
Expression and Nature of the OX-44 Antigen.
￿
The OX-44 mAb resulted from
an immunization of mice with rat T blasts, in which mAbs were first detected by
binding to T blasts and then screened with the FACS on other lymphoid cell
population to detect any interesting labeling patterns. Fig. 1 a shows that all T
blasts were labeled by the antibody; this was also the case for lymph node cells
although two modes of labeling intensity were seen (Fig. 1 b). The more weakly
labeled cells were T lymphocytes as shown by the fact that the low intensity peak
was shifted to denser labeling when OX-19 mAb, which labels T cells but not
most B cells, was added with OX-44 antibody (Fig. 1 e). A large fraction of bone
marrow cells were labeled (Fig. 1 c) and these include the lymphoid and neutro-
phil populations. The antibody did not label erythrocytes (data not shown) and
the negative cells in the bone marrow may be of the erythroid lineage. The
labeling of thymocytes was of most interest (Fig. 1 d) because in this case only
12% of cells showed detectable labeling. These included the larger cells among
the thymocytes as assessed by their scatter profiles in the FACS (Fig. If-h). In
22 different labeling experiments of HO rats aged 6-8 wk the mean labeling
with OX-44 mAb was 12.2% ± SD 1.9%.
In other studies (data not shown) it was found that OX-44 labeled all nucleated
peritoneal cells and dendritic cells obtained from lymph draining the gut. The
results of all the labeling studies indicate that OX-44 may label all cells of the
lymphoid and myeloid lineages with the exception of the majority of thymocytes.
Preliminary experiments with immunoperoxidase labeling on tissue sections
from liver, kidney, and brain show some OX-44 staining. Part of this seemed to
be due to a nonspecific nuclear crossreaction, whereas the rest appeared to
correspond to the presence of leukocytes in these tissues (data not shown) .
Immunoprecipitation studies identified the OX-44 antigen as a broad band of
about 43,000 mol wt in the unreduced or reduced state (Fig. 1 i). The diffuse
nature of the band obtained after SDS-PAGE was not due to technical problems
because other antigens run on the same gels gave much sharper bands (not
shown). The heterogeneity could be due to diversity in carbohydrate attached
to the OX-44 antigen.
Thymocytes Labeled by the OX-44 mAb.
￿
The relationship of the OX-44+ and
OX-44- thymocytes to subsets defined by other mAbs was studied by FACS
analysis on unfractionated thymocytes or cells obtained after rosette depletion
of thymocytes labeled with various mAbs. Fig. 2, a and b, shows labeling of4
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FIGURE 1 .
￿
Distribution and nature of the OX-44 antigen. (a-h) Cells were incubated with
mAb(s) for 60 min at 4°C, washed, labeled with RAM-FITC, and analyzed on the FACS II
(B-D FACS Systems, Becton Dickinson & Co ., Sunnyvale, CA) . Profiles (a-d) show MRC 0X-
44 labeling ofT lymphoblasts, lymph node cells (LNC) (with negative control), bone marrow
(BM), and thymocytes . (e) Labeling ofLNCwhen OX-44andOX-19mAbs were used together
in the first step . (fand g) Forward light scatter (FSC) profiles of whole, MRC OX-44- , and
MRC OX-44+ thymocytes . FLI, fluorescence . (i) Immunoprecipitation of the MRC OX-44
antigen : material precipitated from "'I surface-labeled TDL lysate was run reduced (RED)
and nonreduced (NON-RED) on 12% SDS-PAGE and visualized by autoradiography . Lane 1,
control mAb; lane 2, MRC OX-44 .PATERSON ET AL .
FIGURE 2 .
￿
Analysis of thymocyte subpopulations . FACS analysis of(a) unseparated, (b)MRC
OX-44- ,and (c) CD4- CD8- thymocytes was carried out using single or multiple mAb labeling
in the first step . Thymocyte populations in panels band c were prepared by rosette depletion .
Figures indicate the percentage of positive cells to the right ofthemarker . Thymocyte subsets
can be calculated from such analyses, as shown in Table I .
undepleted thymocytes and of OX-44- cells with mAbs against rat CD4, CD8,
class I, and MRC OX-44 antigen either alone or in combination with each other
whereas Fig . 2c shows labeling of CD4-CD8- cells .
The results for unfractionated thymocytes (Fig . 2a showed that a majority of
OX-44' cells were negative for either CD4 or CD8 antigen, or both, inasmuch
as when cells were incubated with OX-44 plus antibodies against CD4 or CD8,
then the small negative peaks seen with labeling of mAbs against CD4 or CD8
alone were substantially reduced . The CD4-, CD8- cells were almost all OX-44'
as shown by labeling with combinations of antibodies (Fig . 2, a and b) and (Fig .
2 c) . In contrast, not all cells singly positive forCD4 or CD8 were OX-44' because
small negative peaks remained in labeling of thymocytes with anti-CD4 or CD8
plus OX-44 (Fig . 2a) and in labeling of OX-44- cells with the anti-CD4 or CD8
antibodies (Fig . 2b) . The significance of these small peaks is proven by the finding
that OX-44- cells were 99.9% labeled by anti-CD4 and CD8 mixed together
(Fig . 2b) . Most CD4+ CD8+ cells were OX-44- , but calculations of subsets from
labeling data as in Fig. 2a always led to the conclusion that a small set of CD4+
CD8+ OX-44' cells was present. The average percentages from seven experi-
ments for subsets defined by CD4, CD8, and OX-44 mAbs are given in Table I .6
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* Mean ± SD from sevenexperiments such as the one shown in Fig. 2.
TABLE I
Thymocyte Subsets Calculatedfrom FRCS Analysis
Subset phenotype
￿
Percent of total population*
CD4- CD8- OX-44+
￿
1.3 ± 0.2
CD4+ CD8+ OX-44+
￿
2.2 ± 1.3
CD4+ CD8+ OX-44- ￿85 .3 ± 1.3
CD4+ CD8- OX-44+
￿
4.8 ± 0.7
CD4+ CD8- OX-44- ￿2 .0 ± 0.6
CD4- CD8+ OX-44+
￿
2.2 ± 0.7
CD4- CD8+ OX-44- ￿1 .9 ± 0.6
FIGURE 3.
￿
In vitro proliferative responses of thymocyte populations. The proliferative re-
sponses of FACS-purified (O) MRC OX-44+ and (0) MRC OX-44- thymocytes are shown in
the (a) Con A response and (b) primary MLR. MRC OX-44- thymocytes were 99.8% pure,
whereas the MRC OX-44+ thymocytes were 94% pure. Cells labeled with MRC OX-44 and
RAM-FITC butnotrun throughthe FACS were used as the unfractionated thymocytecontrol
(A). (c) The Con A response of (O) CD4- CD8- and (A) unfractionated thymocytes. CD4-
CD8-thymocytes were prepared by rosette depletion followed by cell sorting, and were 99.8%
pure. Points are means ± I SD using four or six replicawells.
Evidence for all these sets can be directly seen from the labeling profiles in Fig.
2 except for the CD4+ CD8+ OX-44+ set.
mAbs against class I MHC antigens are known to label a subfraction of
thymocytes (15) and the OX-44+ set was found to overlap with class I+ cells. Fig.
2a shows labeling of thymocytes with OX-27 (anti-class I) mAb, and comparison
of this with Fig. 2b shows that removal of OX-44+ cells resulted in the loss of
cells that were heavily labeled with OX-27 mAb. The CD4- CD8- cells were all
class I+ (Fig. 2c), as were all cells singly positive for CD4 or CD8 (not shown) .
The class I- fractions are all found in the CD4+ CD8+ set but a minority of CD4+
CD8+ cells are weakly positive for class 1.
Proliferation of Thymocyte Subsets In Vitro.
￿
The Con A stimulation assay (Fig.
3a) and MLR (Fig. 3b) were used to assess the proliferative capacity in vitro of
various thymocyte subsets isolated using the FACS or by rosette depletion. In
neither assay did OX-44- cells show any proliferation while OX-44+ cells were
potent responders. The enrichment of activity shown by OX-44+ cells in com-
parison with unseparated thymocytes was consistent with the total activity of
unseparated cells being due to the OX-44+ cells. It should be noted that OX-44-
cells failed to respond despite the fact that, in the Con A stimulation assay,
optimal conditions were used including the presence of irradiated syngeneic
spleen cellsas asource ofdendritic cellsand T helper cells, as well as a supernatantPATERSON ET AL .
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FIGURE 4.
￿
Labeling of L-CA allotypes by monoclonal antibodies. The mAb NDS 58 labels
(a) all HO L-CAL2 thymocytes but (b)no HO L-CALL thymocytes. Thymocytes from an HO
L-CA 1 .2 rat partially reconstituted with HO L-CAI . I thymocytes using the assay of Gold-
schneider et al . (27) are labeled with (c) NDS 58 and (d) 8G6 .L
from Con A-activated T cells that contains T cell growth factors . When the
assay was performed using Con A alone, the same results were obtained but the
proliferation was reduced (data not shown) .
Because OX-27 (class I) recognizes a subset of thymocytes containing all the
OX-44+ cells, similar experiments to those above were carried out with FACS
purified OX-27' and OX-27- cells . The results showed that all cells capable of
proliferation were within the OX-27+ population . The OX-27- cells gave no
response (data not shown) .
The responsiveness of CD4- CD8- thymocytes was also tested in the in vitro
assays . In the Con A assay this cell population did show a response (Fig . 3 c), but
the level was not enriched in comparison with unseparated cells . The CD4-
CD8- cells are virtually all OX-44+, but this subfraction of the OX-44+ cells
would appear to contribute little to the enriched response of the total OX-44+
population . The cells most active in proliferation are to be found in the CD4+
CD8- and/or CD4- CD8+ fraction of the OX-44+ cells .
Thymic Regeneration Assay.
￿
The intrathymic regeneration assay as described
by Goldschneideret al . (27) was used to assay for thymopoietic potency of various
thymocyte subsets. In this assay, rats bred by S . V . Hunt to be congenic for the
RT-7 alloantigen locus, which encodes the L-CA, were used and the donor cells
were distinguished from host by labeling with mAbs against the RT-7 allotypes .
Fig . 4,a and b, shows that the NDS58 mAb labels all thymocytes from the HO
(I:CA 1 .2) strain whereas the thymocytes from the congenic partner strain HO
(L-CA 1 .1) are completely negative . The 8G6.1 mAb has the opposite specificity
(not shown) . Fig . 4, c and d, shows the labeling of thymocytes from aHO (L-
CA1.2) strain animal injected intrathymically with HO (L-CA1 .1) strain thymo-
cytes, and chimerism at the level of 11.3% is clearly demonstrated .
The thymopoietic potency of OX-44- cells and CD4- CD8- cells isolated by
rosette depletion was tested (FACS separation of cells could not be used because
the cell number requiring separation was too great) . In experiments 3, 4, and 5
in Table 11, the potency of the OX-44- fraction was ^-5-10% of that given by
unfractionated cells whereas in experiments 6 and 7 no thymopoietic activity at
all was shown by the OX-44- cells . The small amount of activity in experiments
3-5 could be due to residual OX-44+ cells because in experiments 3 and 4
depletions of 74% and 67% efficiency were obtained whereas in experiments 6
and 7 the depletions were 100% effective (100% efficient means postdepletion
labeling was : negative control on FACS analysis, insufficient data to estimate
efficiency in experiment 5) .
Considerable enrichment of thymopoietic activity was seen in theCD4- CD8-8
￿
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]'he assay of Goldschneider et al . (27) was used to assess the ability of different thymocyte subsets to repopulate a thymus in vivo.
140 congenic strains were used . After 600 rad of irradiation, 1 ..-CA 1 .2 recipients were injected intrathymically with LCALI donor
cells, killed 2 wk later, and the percentage of donor thymocytes assessed by FAGS analysis . Table summarizes data from all
experiments performed.
* Donor populations prepared by rosette depletion, see text for details of purities.
$ Percent donor cells calculated by subtracting NDS 58 labelling from OX-1 labelling (OX-1 always gave 99.7-99.9% labelling) .
4 F:ach figure represents one animal .
cells (almost all OX-44+, Fig. 2c) . This result is in accord with data in the mouse
(16) and, in addition, showed that the poor activity of the OX-44- cells could
not be explained by artifacts in the isolation of cells by rosette depletion . The
CD4` CD8- cells were 10-20 times more potent than the unfractionated thy-
mocytes compared with a theoretical expected enrichment of 70-fold if all the
activity were in this subset . The low experimental value may be due to some loss
of functional viability in the rosetted cells compared with unfractionated cells,
or to the possibility that the thymopoietic activity is due to a subset within the
CD4- CD8- cells that is recovered with lower efficiency than the bulk CD4`
CD8` population . A third possibility is that some cells in the OX-44' set other
than theCD4-CD8- OX-44' cells may have thymopoietic activity . It is not likely
that the CD4-CD8- set contained many cells of lineage other than T lymphoid
inasmuch as almost all cells were weakly OX-19+ (rat CD5 or Ly-1) (23) and
mAbs recognizing class 11 MHC, surface Ig, or C3b receptor only gave ^-5%
labeling (data not shown) .
Localization of the OX-44' Cells.
￿
This was studied in tissue sections using the
immunoperoxidase technique with the results shown in Fig. 5 . Unlabeled cells
could not be seen in the medulla where positive cells with both lymphoid and
dendritic morphology were seen (Fig . 5a). In the cortex most lymphoid cells
were OX-44- . This is consistent with the fact that most CD4+ CD8' cells are
OX-44- and that these cells are known to exist in the cortex, whereas the medulla
mostly contains the cells positive for CD4 or CD8 but not both (data for CD8
labeling is shown in Fig. 5 c) . Small numbers of OX-44' cells are scattered
throughout the cortex : some have irregular morphology, shown by the star ;PATERSON ET AL.
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others are small round cells as shown by arrows in Fig. 5b. All peripheral
leukocytes appear to be OX-44+ and thus the sections were stained with various
mAbs against macrophages to see if these might account for all the OX-44+
cortical cells. The OX-42 mAb, which labels many rat macrophages and may be
the equivalent of mouse Mac-1, labeled few cells in the thymus sections (Fig. 5d)
but the ED-2 mAb stained considerable numbers of cortical (but not medullary)
macrophages (Fig. 5e) in accord with the data of Dijkstra et al . (25). However,
ED-2+ cells did not appear to account for the small rounded cortical cells.
The OX-44+ cells include those that express large amounts of class I MHC
antigens, and the localization of class I+ cells was studied in chimeric animals.
Class I on leukocytes cannot be visualized in the normal thymus owingto staining
of epithelial cells (Fig. 5f ), and thus expression of leukocyte class I was studied
in HO.B2 (RT1°) animals reconstituted with HOM (RT1°) X HO (RT1`) bone
marrow cells. The donor-derived class I could then be detected with the OX-27
mAb which is specific for RT1` while all class I was detected with the OX-18
mAb which recognizes a common determinant. The results for OX-27 labeling
in sections from the chimeric thymus (Fig. 5g) were very similar to those seen
with OX-44 labeling in the chimeric (Fig. 5h) or normal thymuses (Fig. 5a).
This experiment additionally established that most of the class I in the thymic
cortex is derived from epithelial cells in that staining of the chimeric thymuses
with the class I-common OX-18 antibody gave the extensive pattern of staining
as shown for normal thymus in Fig. 5f(OX-18 data not shown).
Extensive cell division is known to occur in the thymic cortex. This was
confirmed in the present series of experiments by injectinganimals intravenously
with 5-bromo-2' deoxyuridine (10 mg/kg body wt), killing them after 30 min,
and detecting cells that had incorporated the metabolite with the mAb BOW.
A thymus section from such an animal stained with Bu20a is shown in Fig. 5i:
there is considerable labeling of cells throughout the cortex, with the highest
density in the outer cortical layer, whereas few medullary cells were labeled.
Analysis of cells isolated from such a thymus showed that 8.1 % of unfractionated
thymocytes were Bu20a+, compared with 7.8% for OX-44- thymocytes. This
suggests that most dividing cells in the cortex are CD4+ CD8+, which agrees with
thedata of Scollayet al. (31) in the mouse. The OX-44- cells cannot be stimulated
to further division with Con A plus growth factors; thus the DNA synthesis in
this set seemslikely to be occurring in the finaldivisions of a cell series undergoing
terminal differentiation. The situation may be similar to that seen in the avian
erythroid series where a set of cell divisions occur along with production of
hemoglobin and other erythroid components to produce a nucleated cell that
does not divide again (32) .
Discussion
The OX-44 mAb labels a small fraction of thymocytes that mediates functions
that are characteristic of the most undifferentiated thymocytes as well as the
thymic cells that are most like mature T cells. An anti-rat mAb with similar
labeling and molecular properties was described by Matsuura et al . (33) but
minimal functional data were reported. An antigen similar to OX-44 has not
been described in other species.
From the current studies we derive the working hypothesis that the OX-44+lO
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FIGURE 5 .
￿
Monoclonal antibody labeling of thymus . HO thymus cryostat sections (5 pm)
were stained with various mAbs using the immunoperoxidase technique . (a) MRC OX-44 . m,PATERSON ET AL.
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cells may include all the cells that are on the differentiation pathway to immu-
nocompetent T cells while the OX-44- compartment represents cells that have
failed some test in differentiation and are fated to die in situ . The following
factors lead to this view: (a) The OX-44- cells were negative for proliferation
in the MLR or by Con A stimulation and had no thymopoiesic activity. Further-
more, it seems unlikely that other functions, for example, for T help or cytotoxic
activity, would be mediated by OX-44- cells because the cells that mediate these
functions would be expected to divide vigorously with Con A stimulation plus
accessory cells and growth factors. Rat thymic T helpers are known to have the
CD4+ CD8- phenotype (8). (b) The OX-44 antigen is a leukocyte-common
antigen apart from its absence from most thymocytes. Otherantigens are known
to be expressed intermittently in a cell lineage (e.g., rat W3/13 antigen is on
stem cells and plasma cells but not on pre-B or resting B cells), but in these cases
the antigen does not label all peripheral leukocytes as is the case for OX-44.
(c) The OX-44 labeling appears to be a more extreme case of a similar pattern
shown by class I MHC antigen, which is also heavily expressed on all leukocytes
except for the CD4' CD8' thymocytes which are weak or negative. It could be
that in thymic differentiation cells that are fated to die first switch off OX-44
expression and then class I.
Regardless ofthis working hypothesis, the OX-44 antigen allows the definition
of new thymic subsets for further study. CD4- CD8- OX-44+ cells constitute the
much-studied "double negative" cells, whereas the CD4+ CD8- OX-44+ and
CD4- CD8+ OX-44+ cells correspond closely to mature phenotype T cells. In
contrast, the CD4+ CD8+ OX-44+, CD4+ CD8- OX-44-, CD4- CD8+ OX-44-
sets have not been previously described and are potentially intermediate cells in
the thymic differentiation pathways. In accord with this view is the finding that
CD4- CD8+ OX-44- cells are a prominent population in thymuses regenerating
after irradiation (manuscript in preparation). Further studies on these subsets
may help in delineation of pathways for thymic differentiation.
Summary
A monoclonal antibody called MRC OX-44 is described that labels all myeloid
cells and peripheral lymphoid cells but only 12% of thymocytes. The OX-44+
thymic cells include most if not all cells found in the medulla but only a small
fraction of the cortical cells. Together with CD4 and CD8 antigens, seven subsets
of thymic cell were defined and it was notable that most CD4- CD8- cells were
OX-44+ whereas almost all CD4+ CD8+ cells were OX-44-. In functional tests,
the OX-44+ cells accounted for all proliferation by thymocytes when stimulated
by allogeneic spleen cells or concanavalin A plus growth factors and OX-44-
cells were completely negative in these assays. Also, in tests for thymopoiesis
medulla; c, cortex. (b) MRC OX-44, high power of cortex. Arrows indicate labeled small
mononuclear cells; star indicates area of irregular non-thymocyte labeling. Other mAbs used
are (c) anti-CD8, (d) OX-42, (e) ED2, and (f) MRC OX-27. Thymus from an MHC class I
chimaeric animal is labeled with (g) MRC OX-27 and (h) MRC OX-44. (i) Bu20a labeling of
thymus from an animal injected with 5-bromo-2' deoxyuridine. (j) Control labeling by 0X-
21 plus RAM-peroxidase. Bar in panel b represents 20 gym; all other sections are at the same
magnification with bar in panelj, representing 80 gm.12
￿
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after intra-thymic injection of cells, all activity was OX-44+. It seems possible
that the OX-44+ set may include all functionally relevant cells in the rat thymus.
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